Oklahoma cannabis regulator to seek authority over delta-8 THC
The Oklahoma Medical Marijuana Authority (OMMA) wants to expand its jurisdiction to cover intoxicating hemp-derived products such as delta-8 THC.
The Oklahoma Medical Marijuana Authority (OMMA) wants to expand its jurisdiction to cover intoxicating hemp-derived products such as delta-8 THC.
New York-based multistate operator Curaleaf has exited the Vermont cannabis market after selling its remaining assets in the state to CBD company Zenbarn Farms.
Canada’s federal health regulator has approved Jazz Pharmaceuticals Canada’s cannabinoid-based medicine Epidiolex as an adjunctive therapy for certain rare and severe forms of epilepsy, allowing the company to bring to market a clinically tested drug with global sales that dwarf those of the nation’s entire medical cannabis industry
A key legislative subcommittee in Kentucky approved an emergency rule designed to regulate intoxicating hemp-derived products differently than nonintoxicating products.
Congress might not pass the 2023 Farm Bill until 2024, a leading Senate Republican recently indicated.
Low-dose CBD products will be legal to buy without a prescription in New Zealand, but it might be a while before they’re available.
Curio Wellness built diversification into its business model to provide backup revenue for the company and to overcome marijuana stigmas.